## Opportunity to Lead Lawsuit
Investors with significant losses may lead the securities fraud class action against Allarity Therapeutics, Inc. known as ticker “ALLR.”
## Important Dates
– **Class Period:** May 17, 2022 – July 19, 2024
– **Lead Plaintiff Deadline:** November 12, 2024
Investors wishing to serve as lead plaintiff in the lawsuit can find more information at www.glancylaw.com/cases/Allarity-Therapeutics-Inc/ or contact Charles H. Linehan of GPM at 310-201-9150 or email shareholders@glancylaw.com.
## Allegations
The complaint alleges that during the Class Period, Allarity Therapeutics, Inc. failed to disclose critical information to investors, leading to misleading statements about the company’s business operations. This has put the company at risk of regulatory scrutiny and legal consequences.
## Stay Informed
Stay updated by following Glancy Prongay & Murray LLP on LinkedIn, Twitter, or Facebook for further developments.
## Details
For inquiries or to learn more about the lawsuit, contact Charles Linehan, Esquire, of GPM at 310-201-9150 or 888-773-9224, or visit www.glancylaw.com.
Contact:
– Glancy Prongay & Murray LLP, Los Angeles
– Charles Linehan, 310-201-9150 or 888-773-9224
– shareholders@glancylaw.com
– www.glancylaw.com
This release could be considered Attorney Advertising in some regions as per applicable laws and ethical guidelines.
**Source:** Glancy Prongay & Murray LLP
—
Market News and Data brought to you by Benzinga APIs